Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. | Graefes Arch Clin Exp Ophthalmol;238(2): 129-37, 2000 Feb. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma.

Lommatzsch, P K; Werschnik, C; Schuster, E.

Affiliation

Lommatzsch PK; Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Germany.

Graefes Arch Clin Exp Ophthalmol ; 238(2): 129-37, 2000 Feb.

Article in En | MEDLINE | ID: mdl-10766281

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Rhodium / Uveal Neoplasms / Brachytherapy / Ruthenium Radioisotopes / Melanoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Graefes Arch Clin Exp Ophthalmol Year: 2000 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Rhodium / Uveal Neoplasms / Brachytherapy / Ruthenium Radioisotopes / Melanoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Graefes Arch Clin Exp Ophthalmol Year: 2000 Document type: Article Affiliation country: Country of publication: